Document Detail

Lymphocyte apoptosis and cell replacement in human liver allografts.
MedLine Citation:
PMID:  12085009     Owner:  NLM     Status:  MEDLINE    
BACKGROUND: Apoptosis of graft-infiltrating T cells has been described after rodent liver transplantation. The aim of this study was to assess lymphocyte apoptosis in human allografts. Additionally, kinetics of leukocyte turnover were studied to determine whether apoptotic cells were likely to be of donor or recipient origin. METHODS: Liver biopsy specimens (n=36) taken between days 3 and 1855 were stained with terminal deoxynucleotidyl transferase dUTP nick end-labeling and anti-CD3 to detect apoptotic lymphocytes. Renal allograft and hepatitis C biopsy specimens served as controls. Donor cell turnover was studied in sex-mismatched grafts using Y-chromosome in situ hybridization to detect recipient cells and double immunostaining for leukocyte phenotyping. RESULTS: T-cell apoptosis was prominent in hepatic sinusoids (72% of biopsy specimens) as early as day 3. It ranged from 0% to 18.2% of CD3+ cells (mean 5.28+/-0.82%) and persisted for >14 days, including time points >1 year. There was no difference between biopsy specimens with or without rejection (6.34+/-1.14% and 4.61+/-1.13%, P=NS). Apoptotic cells in portal tracts were less frequent (33% of biopsy specimens) and less abundant (1.13+/-0.36%, P<0.0001). No lymphocyte apoptosis was seen in renal allograft biopsy specimens or hepatitis C biopsy specimens, indicating that it is a distinctive feature of the liver allograft. Persisting lymphocyte apoptosis even after donor lymphocytes had been replaced suggests that recipient lymphocyte deletion must occur. Donor Kupffer cells persisted for many months. CONCLUSIONS: Our results suggest that the sinusoidal microenvironment promotes recipient lymphocyte apoptosis, which may account for the improved outcome of liver grafts compared with other organ allografts.
Andrew D Clouston; Julie R Jonsson; Glenda A Balderson; Jonathon Fawcett; Stephen V Lynch; Anne Kelso; Elizabeth E Powell
Related Documents :
2318989 - Monitoring rejection after heart transplantation: cytoimmunological monitoring on blood...
3305819 - Heart allograft rejection under varying immunosuppressive protocols as evaluated by end...
17206459 - A comparison of myocardial perfusion and rejection in cardiac transplant patients.
11967039 - Persistent rejection of peritubular capillaries and tubules is associated with progress...
11095659 - De novo induction of endothelial l-selectin ligands during kidney allograft rejection.
19379149 - Plasmapheresis and intravenous immunoglobulin in early antibody-mediated rejection of t...
22160719 - Reverse signaling through the costimulatory ligand cd137l in epithelial cells is essent...
4550129 - Ileocolonic problems after cadaveric renal transplantation.
9113449 - The fate of renal transplants in patients with iga nephropathy.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Transplantation     Volume:  73     ISSN:  0041-1337     ISO Abbreviation:  Transplantation     Publication Date:  2002 Jun 
Date Detail:
Created Date:  2002-06-26     Completed Date:  2002-07-11     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  0132144     Medline TA:  Transplantation     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1828-34     Citation Subset:  IM    
Department of Pathology, Mayne Medical School, University of Queensland, Herston Road, Herston, Brisbane, Australia 4006.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Acute Disease
Apoptosis / immunology*
Cell Division / immunology
Graft Rejection / immunology,  pathology
In Situ Nick-End Labeling
Kupffer Cells / pathology
Liver / immunology,  pathology*
Liver Transplantation / immunology*
Lymphocytes / pathology*
Sex Factors
Transplantation, Homologous

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  MDR1 gene expression in peripheral blood mononuclear cells after liver transplantation.
Next Document:  FKBP12 is the only FK506 binding protein mediating T-cell inhibition by the immunosuppressant FK506.